TAP
64
4
UHS
54
-4
DOV
73
4
MRO
46
3
DGX
48
-3
MPC
47
3
DOW
30
2
FLS
76
-2
DD
61
4
NOV
58
-2
DUK
50
-2
ABT
57
-5
DVA
72
-3
NTAP
61
-3
CSX
68
3
STX
52
-4
AMG
43
3
SYY
47
-2
GS
75
-4
TRV
56
-2
TAP
64
4
UHS
54
-4
DOV
73
4
MRO
46
3
DGX
48
-3
MPC
47
3
DOW
30
2
FLS
76
-2
DD
61
4
NOV
58
-2
DUK
50
-2
ABT
57
-5
DVA
72
-3
NTAP
61
-3
CSX
68
3
STX
52
-4
AMG
43
3
SYY
47
-2
GS
75
-4
TRV
56
-2
Financhill
Back

Akebia Therapeutics Vs. Aritzia Industry Stock Comparison

Buy
63

AKBA
Akebia Therapeutics

Last Price:
1.89
Seasonality Move:
44.29%
Sell
40

ATZAF
Aritzia

Last Price:
32.69
Seasonality Move:
14.48%
Buy
63
Akebia Therapeutics (AKBA) is a Buy

Is Akebia Therapeutics a Buy, Sell or Hold?

  • The current Akebia Therapeutics [AKBA] share price is $1.92. The Score for AKBA is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • AKBA is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
Aritzia (ATZAF) is a Sell

Is Aritzia a Buy, Sell or Hold?

  • The current Aritzia [ATZAF] share price is $33.13. The Score for ATZAF is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • ATZAF is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AKBA Stock Price Chart

What is Akebia Therapeutics's stock price today?

  • The Akebia Therapeutics share price today is $1.92
    The current trend is moderately bullish and AKBA is experiencing slight selling pressure.

ATZAF Stock Price Chart

What is Aritzia's stock price today?

  • The Aritzia share price today is $33.13
    The current trend is relatively stagnant and ATZAF is experiencing slight buying pressure.

AKBA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.15 Buy
Relative Strength Index (14 RSI): 66.7 Buy
Chaikin Money Flow: -753866 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (1.39 - 1.87) Buy
Bollinger Bands (100): (1.15 - 1.63) Buy

ATZAF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.72 Sell
Relative Strength Index (14 RSI): 51.58 Buy
Chaikin Money Flow: 485 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.46 - 34.6) Buy
Bollinger Bands (100): (30.22 - 35.52) Buy

AKBA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 1.92 Sell
20-day SMA: 1.71 Buy
50-day SMA: 1.5 Buy
200-day SMA: 1.41 Buy
8-day EMA: 1.89 Buy
20-day EMA: 1.75 Buy
50-day EMA: 1.57 Buy
200-day EMA: 1.38 Buy

ATZAF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.85 Buy
20-day SMA: 31.82 Buy
50-day SMA: 34.06 Sell
200-day SMA: 29.54 Buy
8-day EMA: 31.74 Buy
20-day EMA: 32.3 Buy
50-day EMA: 33.02 Buy
200-day EMA: 30 Buy

Akebia Therapeutics Earnings Growth & AKBA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.14 per share, and an increase next year of $0.01 per share.

Aritzia Earnings Growth & ATZAF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.68 per share, and an increase next year of $0.57 per share.

Akebia Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Aritzia Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):